As elections near, Biden promotes ‘whole-of-government’ effort to cut cancer death rates and strengthen the biopharma and biotech sectors. International partners welcome, up to a point
WHO is creating new guidelines to stop lab leaks and the development of bioweapons. But scientists, focused on projects and funding, see only the benefits, rather than the risks, of their work, report warns.
It is getting ever easier to create deadly pathogens in the lab. Research funders, universities and governments need to come together under a new global body to tame this risk, experts warn.
The UK government trumpets the move as an advantage of Brexit, and plant scientists are supportive. Some researchers believe it could prefigure similar moves to ease rules in the EU
Three life sciences and healthcare networking organisations in the UK have made an agreement with MassBio to promote the biotechnology industry in both regions.
Cash-rich pharma is dropping any pretence they are buying cash-strapped biotech for access to innovative technology. What it wants is products. Let’s hope it doesn’t suffocate the feedstock of innovation in the process.
Receive the Funding Newswire [full access requires a subscription] each Tuesday, our Policy Bulletin each Thursday, and news about bridging Europe’s east-west innovation gap twice a month in The Widening.
A unique international forum for public research organisations and companies to connect their external engagement with strategic interests around their R&D system.